| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |